Summary by Moomoo AI
YICHANG EAST SUNSHINE CHANGJIANG PHARMACEUTICAL CO., LTD. (EAST SUNSHINE CHANGJIANG PHARMACEUTICALS) FILED ITS LATEST MONTHLY STATEMENT OF CHANGES IN SECURITIES WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON FEBRUARY 29, 2024. The report shows that as of the end of February 2024, the total authorized/registered share capital of the company was RMB879,967,700, of which the number of H shares remained at 653,767,700 shares with an face value of RMB 1 per share, with no increase or decrease. The equity portion also remained at 226,200,000 shares, with a face value of RMB 1 per share, and did not decrease this month. THE REPORT ALSO CONFIRMS THAT THE COMPANY HAS NO CHANGES IN STOCK OPTIONS, WARRANTS, CONVERTIBLE STOCK NOTES OR OTHER RELATED SHARES. The report was submitted by the Joint Secretary of the Joint Undertaking, Peng Chi-yun, on 1 March 2024.